5590 results
Refine Your Search
Advocating for pediatric patients and survivors
Supporting children's access to cancer care.Blood Cancer United Office of Public Policy supports policies that break down barriers pediatric patients …
Advocacy
Immune-Onc Therapeutics
In , LLS made an equity investment in Therapeutics. is a cancer immunotherapy company dedicated to the discovery and development of novel myeloid c…
Sanofi Completes Kiadis Acquisition
April , - Sanofi and Kiadis announce today the successful completion of Sanofi’s acquisition of Kiadis, a biopharmaceutical company developing next …
Everyday Heroes Fight for a Cancer-Free Future
The Leukemia & Lymphoma Society 32nd annual Man & Woman of the Year campaign bringing together diverse communities across the country
Celebrating Survivorship - Florie Gomatos
My name is Florie and I am years old and my family includes my husband, three adult kids and their spouses, grandchildren and three dogs. I was diagn…
FDA Approves Isatuximab for Relapsed/Refractory Multiple Myeloma
The U.S. Food and Drug Administration (FDA) approved isatuximab (Sarclisa) in combination with carfilzomib and dexamethasone to treat adult patients w…
News Release
LLS Statement on Anti-Asian Violence and Discrimination
The Leukemia & Lymphoma Society condemns violence and discrimination against members of the Asian, Asian American, and Pacific Islander community, whi…
FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma
Chimeric Antigen Receptor (CAR) T is on a roll. Today marks the seventh approval of CAR T therapy since the first approval in . While all prior appro…
Thank you
Way to go! You've successfully submited your story to Blood Cancer United for possible use on our website. Your story is important to us and we apprec…
LLS TAP announces five new investments supporting next generation immunotherapies
RYE BROOK, N.Y., April , /PRNewswire/ -- The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) today announced five new investments…
Kevin
My brest friend, Kevin McDowell has dreamed of going to the Olympics for triathlon since he was years old. Shortly after winning bronze at the ITU Ju…
Covid-19 Vaccine Safety Among Blood Cancer Patients
Update: October , 2021Consistent with earlier findings, the most commonly reported local reactions after a third mRNA vaccine (Moderna or Pfizer) am…
Because You Volunteer, Your Impact Creates a Ripple Effect
When you commit time and talent to a nonprofit’s mission – no matter how you choose to get involved – you become a volunteer, and the impact of your e…
January 2021
In the month of January, we have identified publications that cited support from the leukemia and Lymphoma Society through our various Research Gran…
Celebrating Survivorship Lesli Dahlke
IN CELEBRATION OF SURVIVING! My Story is not unlike any other cancer patient diagnosed with the words, ”You have cancer”. Stunning words you never wa…
Leukemia research
Nearly every breakthrough in cancer treatment has emerged from our support of leukemia research, from chemotherapy to groundbreaking CAR immunotherap…
Research: Grants
Research: TAP
Lymphoma research
Our investment in lymphoma research has led to significant advances, such as rituximab (Rituxan®) and innovative immunotherapy, such as the first firs…
Research: Grants
Research: TAP
Accelerating progress in cancer research and development
Support robust federal funding dedicated to cancer research. Blood Cancer United aims to enact policies that enhance clinical trials, promote drug dev…
Advocacy
Improving the quality of health insurance
Cancer patients need meaningful health insurance coverage. That means health plans must cover essential care, maintain sufficient provider networks, a…
Advocacy